Cryoport enhances cold chain tracking with SmartPack II


Company targets coming cellular therapy, regenerative medicine boom

Saying that his company is preparing for future business in cellular therapy and related live-cell treatments, even ahead of a commercial market, Jerrell Shelton, president of Cryoport, is promoting the company’s newly introduced SmartPack II condition-monitoring system. The electronic monitoring and communications device is meant to accompany the company’s Express Shippers, which are engineered metal containers, with cooling provided by liquid nitrogen (-196°C). SmartPack is designed to communicate with the company’s Cryoportal, a cloud-based communications system that enables clients to monitor shipments en route while confirming environmental conditions and transfers or deliveries (geolocation). Cellular, Wi-Fi and satellite-based communications are all enabled.

While there are numerous other condition-monitoring devices on the market, Shelton says that the proprietary combination of SmartPack features, together with Cryoportal, offer clients a tailored, effective solution for shipping valuable samples, clinical trial materials and commercial products. (In its latest annual statement, the company says that it has won its first commercial-product contract with a biotech product that has a $4-billion market; the client was not revealed.) The Cryoport containers are currently available in three sizes (the equivalent of 75, 500 or 1,500 2-mL vials), and with temperature control and related features that cover deep frozen, frozen and special-purpose temperature ranges.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.